Neuroscience Companies in Switzerland

Aequicens was founded at the start of 2018 in Geneva, Switzerland. Aequicens takes a scientific approach to artificial intelligence-based analytics. We rigorously test our solutions before making them available. We build new intelligence and support your business through the innovation circle. We also rely on thinking outside the box to find new ways to compress, abstract, and preprocess data to ensure only the pertinent information is used to construct our models. Underneath it all, we are a knowledge company, not only a technology company, we sell understanding. Our philosophy is to use artificial intelligence when it is useful, not just impressive.

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.

We take immersion to innovative heights. Our soft robotic interfaces interact with the skin, combining temperature, pressure and vibration to create a realistic tactile experience while proprietary algorithms mimic how the brain merges touch with vision, sound, proprioception and movement to create and restore lifelike multi-sensory experiences. Our technology creates a sensory experience with lived emotions, truly connecting the body with the digital world. Its uses in our daily lives are limitless.

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.

Our mission at OVOMIND is to transform the game experience by making emotions a crucial component of interaction. We do this by using smartbands to read players' biosignals, which creates an unmatched enhanced augmented reality gaming experience. Get ready for an unforgettable and thrilling experience as you immerse yourself in a world where emotions and gaming collide.

Demiurge pioneers high-accuracy MoA-based prediction of clinical trial outcomes. * Posts here are for information only without any warranty of any kind.

At Neurosoft Bioelectronics, we strive at improving the care of patients who suffer from neurological disorders by developing soft implantable electrodes to interface with the nervous system. We have established a unique technology that allows to manufacture extremely compliant neural interfaces that can achieve long-term bio-integration in the body. These devices will improve therapeutic outcomes in patients as well as open up new applications for neural interfaces that were so far impossible.

Amal Therapeutics is a Biotechnology company located in 64 av., de la Roseraie, 1205 Geneva, Switzerland.